Joseph Douglas Lyon - Chief Accounting & Technology Officer at Corcept Therapeutics Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Accounting & Technology Officer
Stock Symbol
CORT on Nasdaq
All Insider Reports
All Insider Reports

Joseph Douglas Lyon - trading volume in the past year for Corcept Therapeutics Inc

Holdings reported by Joseph Douglas Lyon for Corcept Therapeutics Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 8.76K $586K $66.92 Feb 3, 2025 Direct
Stock option (right to buy) 96.6K Feb 3, 2025 Direct Common Stock

Transactions reported by Joseph Douglas Lyon for Corcept Therapeutics Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.